
Pharmacally
otsuka
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in otsuka
Health TidingsOtsuka Seeks Japan Approval for First-Line Use of Iclusig in Ph+ ALLOtsuka Pharmaceutical has submitted a supplemental application in Japan to expand Iclusig into the first-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.Fact-Checked
Mergers & AcquisitionsOtsuka to Acquire Transcend Therapeutics in Up to $1.2B Deal to Advance PTSD Therapy TSND-201Otsuka has agreed to acquire Transcend Therapeutics for up to $1.225 billion, gaining TSND-201, a rapid-acting PTSD therapy that demonstrated significant symptom improvement in the Phase 2 IMPACT-1…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.